Broncus Holding Corp. engages in the research and development, and manufacturing, and commercialization of medical devices and consumables. The company is headquartered in Hangzhou, Zhejiang and currently employs 193 full-time employees. The company went IPO on 2021-09-24. The firm's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.
02216.HK stock price ended at $2.45 on 星期五, after rising 1.24%
On the latest trading day Jan 16, 2026, the stock price of 02216.HK rose by 1.24%, climbing from $2.47 to $2.45. During the session, the stock saw a volatility of 5.93%, with prices oscillating between a daily low of $2.36 and a high of $2.50. Notably, trading volume dropped by 226.5K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 629.5K shares were traded, equating to a market value of approximately $1.2B.